Navigation Links
Penn Medicine team reports on study of first 59 leukemia patients who received cell therapy
Date:12/7/2013

erapy, with seven of those experiencing a complete remission of their disease. Results of both the completed pilot study of 14 CLL patients (Abstract #4162) and results thus far of the first 18 patients in a Phase II, dose-optimization trial (Abstract #873) will be presented.

  • 19 of 22 pediatric patients with ALL (86 percent) experienced complete remissions. The first pediatric patient treated with the protocol, who is now 8 years old, remains in remission 20 months later. Five patients have relapsed, including one whose tests revealed new tumor cells that do not express the protein targeted by the reprogrammed cells. (Abstract #67)

  • All five of the first adult ALL patients treated thus far experienced complete remissions, the longest of which continues six months after treatment. One patient subsequently underwent a bone marrow transplant and remains in remission. One patient relapsed after three months with disease that also tested negative for the engineered cell target. (Abstract #67)

    Building a Cancer-Killing CAR

    The investigational treatment pioneered by the Penn team begins by removing patients' T cells via an apheresis process similar to blood donation, then reprogramming them in Penn's cell and vaccine production facility with a gene transfer technique using a lentivirus vector. The newly built T cells target tumor cells using an antibody-like protein, called a chimeric antigen receptor (CAR), which is expressed on the surface of the T cells and designed to bind to a protein called CD19, which is found on the surface of the cancerous B cells associated with both CLL and ALL.

    The modified cells are then infused back into the patient's body following lymphodepleting chemotherapy. In the body, these "hunter" T cells both multiply and attack. A signaling domain built into the CAR promotes rapid growth of these cells, building an army of tumor-killing cells that tests reveal can grow to more than 10,000 n
    '/>"/>


  • Contact: Holly Auer
    holly.auer@uphs.upenn.edu
    215-200-2313
    University of Pennsylvania School of Medicine
    Source:Eurekalert  

    Page: 1 2 3 4 5

    Related biology news :

    1. Singapore joins global translational medicine network as Asia-Pacific hub
    2. Penn Dental Medicine team identifies molecule critical to healing wounds
    3. Sons of cocaine-using fathers may resist addiction to drug, Penn Medicine study suggests
    4. Osteoarthritis medicine delivered on-demand
    5. College of Veterinary Medicine researcher doubles down on deadly, infectious cat diseases
    6. Ludwig scientist Richard D. Kolodner elected to the Institute of Medicine
    7. Leader of smoking cessation and tobacco prevention efforts receives Institute of Medicines 2013 Lienhard Award
    8. Institute of Medicine Elects 70 New Members, 10 Foreign Associates
    9. Carnegie Mellon President Subra Suresh elected to Institute of Medicine
    10. Institute of Medicine honors members for outstanding service
    11. Wyss Institute core faculty member elected to the Institute of Medicine of the National Academies
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    Related Image:
    Penn Medicine team reports on study of first 59 leukemia patients who received cell therapy
    (Date:7/30/2014)... (ACS) announced today that David L. Kaplan, Ph.D., will ... & Engineering as editor-in-chief. With the first issue ... will feature high-quality research in the rapidly burgeoning field ... materials that interact with living or biological systems. , ... tremendous growth in the field of biomaterials over the ...
    (Date:7/30/2014)... San Antonio Life Sciences Institute (SALSI), a joint venture ... and The University of Texas Health Science Center at ... Initiative Pilot Program. The winners, Emily Boice from UTSA ... receive $25,000 for their project titled, "Novel engineered ferritins ... environment." , Boice and Huang,s research is focused on ...
    (Date:7/30/2014)... infection could be as simple as inserting a medicated, ... of Washington bioengineers have discovered a potentially faster way ... contracting HIV. Their method spins the drug into silk-like ... releasing higher doses of the drug than possible with ... "This could offer women a potentially more effective, discreet ...
    Breaking Biology News(10 mins):ACS Biomaterials Science & Engineering: Brand-new journal launches in 2015, names editor 2Dissolvable fabric loaded with medicine might offer faster protection against HIV 2Dissolvable fabric loaded with medicine might offer faster protection against HIV 3
    ... a moth gene has been shown to be able to produce ... study led by researchers from Lund University in Sweden. In the ... tailored production of pheromones for pest control. Male moths can ... of several hundred metres. The females produce sexual pheromones scent ...
    ... International Osteoporosis Foundation (IOF) and ESCEO have announced that ... to the European Congress on Osteoporosis & Osteoarthritis (ESCEO13-IOF) ... indicate a record number of delegates, making the ESCEO13-IOF ... research in the field, as well the world,s largest ...
    ... the name suggests, you can,t digest resistant starch so it ... form it entered your mouth. As unlovely as that seems, ... things, including decreasing bowel pH and transit time, and increasing ... growth of good bugs while keeping bad bugs at bay. ...
    Cached Biology News:Towards a new moth perfume 2Study shows that diet of resistant starch helps the body resist colorectal cancer 2
    (Date:7/31/2014)... 2014 Sales Horizons, a leader in ... sales training course – Mastering the Complex Sale ... , Drawn from proven sales training programs used by ... Complex Sale online sales training course is available to ... face-to-face contact with customers, like technical support, engineers, clinical ...
    (Date:7/30/2014)...  Decision Resources Group finds that the majority ... the United States believe that ... be the level of savings achievable by their ... cost to patients. Payers plan to leverage preferential ... expectations in order to encourage physician prescribing of ...
    (Date:7/30/2014)... 30, 2014 While administrative claims ... services research for a relatively long period of ... regarding the use of these ‘big data’ for ... By combining today’s powerful computer technology with the ... ‘big data’ holds significant promise for identifying optimal ...
    (Date:7/30/2014)... NewYork (PRWEB) July 30, 2014 ... the increase of personal health expenditure as well ... health care system, China diagnostic reagent industry has ... occupy over 90%. In 2013, Chinese in vitro ... RMB16.61 billion came from in vitro diagnostic reagents. ...
    Breaking Biology Technology:Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 2Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 3Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 3Leveraging ‘Big Data’ - Methodological Considerations in Health Services Research, New Webinar Hosted by Xtalks 2China Diagnostic Reagent Industry Report, 2013-2016 | Researchmoz 2China Diagnostic Reagent Industry Report, 2013-2016 | Researchmoz 3
    ... SANFORD, Maine, Jan. 31, 2012  Maine Manufacturing, LLC announced ... GE Healthcare granting Maine Manufacturing the exclusive right to ... line.  Maine Manufacturing, which has been manufacturing the FAST ... FAST Slides and accessories including FAST Quant, direct to ...
    ... Jan. 26, 2012 Life Technologies Corporation (NASDAQ: ... company,s presentations at the following upcoming investment conferences in ... Life Technologies will present at the Leerink Swann 2012 ... a.m. ET. Life Technologies will also present ...
    ... 2012  ZyGEM Corp. Ltd., a developer and marketer of ... nucleic acids, today announced that it has signed an ... DNA and RNA extraction kits.  SDL was established by ... as part of the Saudi Arabian government,s drive to ...
    Cached Biology Technology:Maine Manufacturing, LLC Announces Global Distribution of FAST® Protein Array Products 2Life Technologies to Present at Upcoming Investment Conferences in February 2ZyGEM to Provide its Unique DNA and RNA Extraction Technology to Middle East Biomedical Innovator Saudi Diagnostics Ltd. 2ZyGEM to Provide its Unique DNA and RNA Extraction Technology to Middle East Biomedical Innovator Saudi Diagnostics Ltd. 3
    Mouse monoclonal antibody raised against a partial recombinant CAPG. NCBI Entrez Gene ID = CAPG...
    ... used to test the crossreactivity of an ... are commonly used as blocking reagents or ... 19 different protein preparations on a nitrocellulose ... species specificity, QC of purified antibodies, selection ...
    ... new HydroFlex platform provides excellent performance, ... of 96-well format applications, including washing ... arrays, and vacuum filtration-to-waste, such as ... on-line control features set new standards ...
    ... Clean and Accurate Results Laser Capture ... the sensitivity and accuracy of molecular assays ... types and multi-cellular structures isolated from whole ... to microdissection-developed in 1996 at the National ...
    Biology Products: